$DBA
INVESCO DB AGRICULTURE FUND

2024 Q1 Form 10-K Financial Statement

#000095017024019060 Filed on February 23, 2024

View on sec.gov

Income Statement

Concept 2024 Q1 2023 Q4 2023
Revenue $9.446M $43.41M
YoY Change -11.09% 103.62%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $1.632M $8.120M
YoY Change -26.43% -45.01%
Operating Profit $7.902M $35.76M
YoY Change -7.25% 393.09%
Interest Expense $40.12K $148.8K
YoY Change -2.96% 53.13%
% of Operating Profit 0.51% 0.42%
Other Income/Expense, Net
YoY Change
Pretax Income
YoY Change
Income Tax
% Of Pretax Income
Net Earnings $129.0M $60.58M
YoY Change 1506.04% -189.12%
Net Earnings / Revenue 1365.75% 139.53%
Basic Earnings Per Share
Diluted Earnings Per Share
COMMON SHARES
Basic Shares Outstanding 32.25M
Diluted Shares Outstanding

Balance Sheet

Concept 2024 Q1 2023 Q4 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $4.721M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $789.2M $719.0M
YoY Change -13.61% -34.1%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities
Total Long-Term Liabilities
Total Liabilities $510.1K $14.70M
YoY Change -89.19% -19.74%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $788.7M $704.3M
YoY Change
Total Liabilities & Shareholders Equity $789.2M $719.0M
YoY Change -13.61% -34.1%

Cashflow Statement

Concept 2024 Q1 2023 Q4 2023
OPERATING ACTIVITIES
Net Income $129.0M $60.58M
YoY Change 1506.04% -189.12%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities $41.24M $448.5M
YoY Change -77.58% -423.54%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid $336.2K $33.90M
YoY Change 497.94%
Common Stock Issuance & Retirement, Net $409.8M
YoY Change -384.05%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -45.97M -443.7M
YoY Change -75.01% -420.13%
NET CHANGE
Cash From Operating Activities 41.24M 448.5M
Cash From Investing Activities
Cash From Financing Activities -45.97M -443.7M
Net Change In Cash -4.721M 4.721M
YoY Change
FREE CASH FLOW
Cash From Operating Activities $41.24M $448.5M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001383082
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2023 us-gaap Forward Contract Indexed To Issuers Equity Settlement Date Or Dates
ForwardContractIndexedToIssuersEquitySettlementDateOrDates
2024-09-30
CY2023 us-gaap Forward Contract Indexed To Issuers Equity Settlement Date Or Dates
ForwardContractIndexedToIssuersEquitySettlementDateOrDates
2024-11-30
CY2023 us-gaap Forward Contract Indexed To Issuers Equity Settlement Date Or Dates
ForwardContractIndexedToIssuersEquitySettlementDateOrDates
2024-07-31
CY2023 us-gaap Forward Contract Indexed To Issuers Equity Settlement Date Or Dates
ForwardContractIndexedToIssuersEquitySettlementDateOrDates
2024-07-31
CY2023 us-gaap Forward Contract Indexed To Issuers Equity Settlement Date Or Dates
ForwardContractIndexedToIssuersEquitySettlementDateOrDates
2024-03-31
CY2023 us-gaap Forward Contract Indexed To Issuers Equity Settlement Date Or Dates
ForwardContractIndexedToIssuersEquitySettlementDateOrDates
2024-02-29
CY2023 us-gaap Forward Contract Indexed To Issuers Equity Settlement Date Or Dates
ForwardContractIndexedToIssuersEquitySettlementDateOrDates
2024-02-29
CY2023 us-gaap Forward Contract Indexed To Issuers Equity Settlement Date Or Dates
ForwardContractIndexedToIssuersEquitySettlementDateOrDates
2024-03-31
CY2023 us-gaap Forward Contract Indexed To Issuers Equity Settlement Date Or Dates
ForwardContractIndexedToIssuersEquitySettlementDateOrDates
2024-03-31
CY2023 us-gaap Forward Contract Indexed To Issuers Equity Settlement Date Or Dates
ForwardContractIndexedToIssuersEquitySettlementDateOrDates
2024-03-31
CY2023 us-gaap Forward Contract Indexed To Issuers Equity Settlement Date Or Dates
ForwardContractIndexedToIssuersEquitySettlementDateOrDates
2024-06-30
CY2022 us-gaap Forward Contract Indexed To Issuers Equity Settlement Date Or Dates
ForwardContractIndexedToIssuersEquitySettlementDateOrDates
2023-09-30
CY2022 us-gaap Forward Contract Indexed To Issuers Equity Settlement Date Or Dates
ForwardContractIndexedToIssuersEquitySettlementDateOrDates
2023-11-30
CY2022 us-gaap Forward Contract Indexed To Issuers Equity Settlement Date Or Dates
ForwardContractIndexedToIssuersEquitySettlementDateOrDates
2023-07-31
CY2022 us-gaap Forward Contract Indexed To Issuers Equity Settlement Date Or Dates
ForwardContractIndexedToIssuersEquitySettlementDateOrDates
2023-07-31
CY2022 us-gaap Forward Contract Indexed To Issuers Equity Settlement Date Or Dates
ForwardContractIndexedToIssuersEquitySettlementDateOrDates
2023-03-31
CY2022 us-gaap Forward Contract Indexed To Issuers Equity Settlement Date Or Dates
ForwardContractIndexedToIssuersEquitySettlementDateOrDates
2023-02-28
CY2022 us-gaap Forward Contract Indexed To Issuers Equity Settlement Date Or Dates
ForwardContractIndexedToIssuersEquitySettlementDateOrDates
2023-02-28
CY2022 us-gaap Forward Contract Indexed To Issuers Equity Settlement Date Or Dates
ForwardContractIndexedToIssuersEquitySettlementDateOrDates
2023-03-31
CY2022 us-gaap Forward Contract Indexed To Issuers Equity Settlement Date Or Dates
ForwardContractIndexedToIssuersEquitySettlementDateOrDates
2023-03-31
CY2022 us-gaap Forward Contract Indexed To Issuers Equity Settlement Date Or Dates
ForwardContractIndexedToIssuersEquitySettlementDateOrDates
2023-03-31
CY2022 us-gaap Forward Contract Indexed To Issuers Equity Settlement Date Or Dates
ForwardContractIndexedToIssuersEquitySettlementDateOrDates
2023-06-30
CY2023 dei Document Type
DocumentType
10-K
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-12-31
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Entity File Number
EntityFileNumber
001-33238
CY2023 dei Entity Registrant Name
EntityRegistrantName
INVESCO DB AGRICULTURE FUND
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
87-0778078
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
c/o Invesco Capital Management LLC
CY2023 dei Entity Address Address Line2
EntityAddressAddressLine2
3500 Lacey Road
CY2023 dei Entity Address Address Line3
EntityAddressAddressLine3
Suite 700
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
Downers Grove
CY2023 dei Entity Address State Or Province
EntityAddressStateOrProvince
IL
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
60515
CY2023 dei City Area Code
CityAreaCode
800
CY2023 dei Local Phone Number
LocalPhoneNumber
983-0903
CY2023 dei Security12b Title
Security12bTitle
Common Units of Beneficial Interest
CY2023 dei Trading Symbol
TradingSymbol
DBA
CY2023 dei Security Exchange Name
SecurityExchangeName
NYSEArca
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
Yes
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
false
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
true
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Public Float
EntityPublicFloat
835822000
CY2024Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
32250000
CY2023 dei Auditor Firm
AuditorFirmId
238
CY2023 dei Auditor Name
AuditorName
PricewaterhouseCoopers LLP
CY2023 dei Auditor Location
AuditorLocation
Chicago, Illinois
CY2023Q4 us-gaap Financial Instruments Owned Us Government And Agency Obligations At Fair Value
FinancialInstrumentsOwnedUSGovernmentAndAgencyObligationsAtFairValue
342956644
CY2022Q4 us-gaap Financial Instruments Owned Us Government And Agency Obligations At Fair Value
FinancialInstrumentsOwnedUSGovernmentAndAgencyObligationsAtFairValue
571698186
CY2023Q4 us-gaap Cash
Cash
4721066
CY2023Q4 dba Receivable From Fund Shares Sold
ReceivableFromFundSharesSold
2074305
CY2023Q4 us-gaap Dividends Receivable
DividendsReceivable
1403400
CY2022Q4 us-gaap Dividends Receivable
DividendsReceivable
1766452
CY2023Q4 us-gaap Assets
Assets
718970873
CY2022Q4 us-gaap Assets
Assets
1091027240
CY2023Q4 dba Payable To Clearing Organizations
PayableToClearingOrganizations
10687335
CY2022Q4 dba Payable To Clearing Organizations
PayableToClearingOrganizations
1359934
CY2023Q4 us-gaap Distribution Payable
DistributionPayable
336157
CY2023Q4 dba Payable For Fund Shares Reacquired
PayableForFundSharesReacquired
3157545
CY2022Q4 dba Payable For Fund Shares Reacquired
PayableForFundSharesReacquired
16131716
CY2023Q4 us-gaap Management Fee Payable
ManagementFeePayable
520593
CY2022Q4 us-gaap Management Fee Payable
ManagementFeePayable
826520
CY2023Q4 us-gaap Commissions Payable To Broker Dealers And Clearing Organizations
CommissionsPayableToBrokerDealersAndClearingOrganizations
2673
CY2022Q4 us-gaap Commissions Payable To Broker Dealers And Clearing Organizations
CommissionsPayableToBrokerDealersAndClearingOrganizations
2140
CY2023Q4 us-gaap Liabilities
Liabilities
14704303
CY2022Q4 us-gaap Liabilities
Liabilities
18320310
CY2023Q4 us-gaap General Partners Capital Account
GeneralPartnersCapitalAccount
830
CY2022Q4 us-gaap General Partners Capital Account
GeneralPartnersCapitalAccount
806
CY2023Q4 us-gaap Limited Partners Capital Account
LimitedPartnersCapitalAccount
704265740
CY2022Q4 us-gaap Limited Partners Capital Account
LimitedPartnersCapitalAccount
1072706124
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
704266570
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
1072706930
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
718970873
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1091027240
CY2023Q4 us-gaap General Partners Capital Account Units Outstanding
GeneralPartnersCapitalAccountUnitsOutstanding
40
CY2022Q4 us-gaap General Partners Capital Account Units Outstanding
GeneralPartnersCapitalAccountUnitsOutstanding
40
CY2023Q4 us-gaap Limited Partners Capital Account Units Outstanding
LimitedPartnersCapitalAccountUnitsOutstanding
33950000
CY2022Q4 us-gaap Limited Partners Capital Account Units Outstanding
LimitedPartnersCapitalAccountUnitsOutstanding
53200000
CY2023Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
20.74
CY2022Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
20.16
CY2023Q4 dba Market Value Per Share
MarketValuePerShare
20.73
CY2022Q4 dba Market Value Per Share
MarketValuePerShare
20.15
CY2023Q4 us-gaap Investment Interest Rate
InvestmentInterestRate
0.0525
CY2023Q4 us-gaap Investment Maturity Date
InvestmentMaturityDate
2024-03-07
CY2023Q4 us-gaap Investment Owned Percent Of Net Assets
InvestmentOwnedPercentOfNetAssets
0.0352
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
24765221
CY2023Q4 us-gaap Investment Owned Underlying Face Amount At Market Value
InvestmentOwnedUnderlyingFaceAmountAtMarketValue
25000000
CY2023Q4 us-gaap Investment Interest Rate
InvestmentInterestRate
0.0524
CY2023Q4 us-gaap Investment Maturity Date
InvestmentMaturityDate
2024-05-30
CY2023Q4 us-gaap Investment Owned Percent Of Net Assets
InvestmentOwnedPercentOfNetAssets
0.4171
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
293737965
CY2023Q4 us-gaap Investment Owned Underlying Face Amount At Market Value
InvestmentOwnedUnderlyingFaceAmountAtMarketValue
300000000
CY2023Q4 us-gaap Investment Interest Rate
InvestmentInterestRate
0.0519
CY2023Q4 us-gaap Investment Maturity Date
InvestmentMaturityDate
2024-06-06
CY2023Q4 us-gaap Investment Owned Percent Of Net Assets
InvestmentOwnedPercentOfNetAssets
0.0347
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
24453458
CY2023Q4 us-gaap Investment Owned Underlying Face Amount At Market Value
InvestmentOwnedUnderlyingFaceAmountAtMarketValue
25000000
CY2023Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
342604310
CY2023Q4 us-gaap Investment Owned Percent Of Net Assets
InvestmentOwnedPercentOfNetAssets
0.487
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
342956644
CY2023Q4 dba Investments In And Advances To Affiliates At Cost
InvestmentsInAndAdvancesToAffiliatesAtCost
119520055
CY2023Q4 us-gaap Investment Owned Percent Of Net Assets
InvestmentOwnedPercentOfNetAssets
0.1699
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
119734949
CY2023Q4 us-gaap Investment Owned Balance Shares
InvestmentOwnedBalanceShares
1133800
CY2023Q4 us-gaap Investment Interest Rate
InvestmentInterestRate
0.0529
CY2023Q4 dba Investments In And Advances To Affiliates At Cost
InvestmentsInAndAdvancesToAffiliatesAtCost
248080509
CY2023Q4 us-gaap Investment Owned Percent Of Net Assets
InvestmentOwnedPercentOfNetAssets
0.3523
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
248080509
CY2023Q4 us-gaap Investment Owned Balance Shares
InvestmentOwnedBalanceShares
248080509
CY2023Q4 dba Investments In And Advances To Affiliates At Cost
InvestmentsInAndAdvancesToAffiliatesAtCost
367600564
CY2023Q4 us-gaap Investment Owned Percent Of Net Assets
InvestmentOwnedPercentOfNetAssets
0.5222
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
367815458
CY2023Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
710204874
CY2023Q4 us-gaap Investment Owned Percent Of Net Assets
InvestmentOwnedPercentOfNetAssets
1.0092
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
710772102
CY2023Q4 us-gaap Good Faith And Margin Deposits With Broker Dealers
GoodFaithAndMarginDepositsWithBrokerDealers
146865000
CY2023Q4 us-gaap Investment Owned Balance Contracts
InvestmentOwnedBalanceContracts
3564
CY2023Q4 us-gaap Investment Owned Underlying Face Amount At Market Value
InvestmentOwnedUnderlyingFaceAmountAtMarketValue
88565400
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
-2696057
CY2023Q4 us-gaap Tax Basis Of Investments Unrealized Appreciation Depreciation Net
TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet
-2696057
CY2023Q4 us-gaap Investment Owned Balance Contracts
InvestmentOwnedBalanceContracts
1405
CY2023Q4 us-gaap Investment Owned Underlying Face Amount At Market Value
InvestmentOwnedUnderlyingFaceAmountAtMarketValue
87513938
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
-1282131
CY2023Q4 us-gaap Tax Basis Of Investments Unrealized Appreciation Depreciation Net
TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet
-1282131
CY2023Q4 us-gaap Investment Owned Balance Contracts
InvestmentOwnedBalanceContracts
1401
CY2023Q4 us-gaap Investment Owned Underlying Face Amount At Market Value
InvestmentOwnedUnderlyingFaceAmountAtMarketValue
45234788
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
-1339435
CY2023Q4 us-gaap Tax Basis Of Investments Unrealized Appreciation Depreciation Net
TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet
-1339435
CY2023Q4 us-gaap Investment Owned Balance Contracts
InvestmentOwnedBalanceContracts
1338
CY2023Q4 us-gaap Investment Owned Underlying Face Amount At Market Value
InvestmentOwnedUnderlyingFaceAmountAtMarketValue
43217400
CY2022Q4 us-gaap Investment Owned Underlying Face Amount At Market Value
InvestmentOwnedUnderlyingFaceAmountAtMarketValue
50000000
CY2022Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
571517656
CY2022Q4 us-gaap Investment Owned Percent Of Net Assets
InvestmentOwnedPercentOfNetAssets
0.533
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
-5650533
CY2023Q4 us-gaap Tax Basis Of Investments Unrealized Appreciation Depreciation Net
TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet
-5650533
CY2023Q4 us-gaap Investment Owned Balance Contracts
InvestmentOwnedBalanceContracts
258
CY2023Q4 us-gaap Investment Owned Underlying Face Amount At Market Value
InvestmentOwnedUnderlyingFaceAmountAtMarketValue
28779900
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
1161102
CY2023Q4 us-gaap Tax Basis Of Investments Unrealized Appreciation Depreciation Net
TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet
1161102
CY2023Q4 us-gaap Investment Owned Balance Contracts
InvestmentOwnedBalanceContracts
2023
CY2023Q4 us-gaap Investment Owned Underlying Face Amount At Market Value
InvestmentOwnedUnderlyingFaceAmountAtMarketValue
55005370
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
-5957186
CY2023Q4 us-gaap Tax Basis Of Investments Unrealized Appreciation Depreciation Net
TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet
-5957186
CY2023Q4 us-gaap Investment Owned Balance Contracts
InvestmentOwnedBalanceContracts
1265
CY2023Q4 us-gaap Investment Owned Underlying Face Amount At Market Value
InvestmentOwnedUnderlyingFaceAmountAtMarketValue
85261000
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
-6678115
CY2023Q4 us-gaap Tax Basis Of Investments Unrealized Appreciation Depreciation Net
TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet
-6678115
CY2023Q4 us-gaap Investment Owned Balance Contracts
InvestmentOwnedBalanceContracts
2052
CY2023Q4 us-gaap Investment Owned Underlying Face Amount At Market Value
InvestmentOwnedUnderlyingFaceAmountAtMarketValue
86101920
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
5543802
CY2023Q4 us-gaap Tax Basis Of Investments Unrealized Appreciation Depreciation Net
TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet
5543802
CY2023Q4 us-gaap Investment Owned Balance Contracts
InvestmentOwnedBalanceContracts
1250
CY2023Q4 us-gaap Investment Owned Underlying Face Amount At Market Value
InvestmentOwnedUnderlyingFaceAmountAtMarketValue
88265625
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
8413856
CY2023Q4 us-gaap Tax Basis Of Investments Unrealized Appreciation Depreciation Net
TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet
8413856
CY2023Q4 us-gaap Investment Owned Balance Contracts
InvestmentOwnedBalanceContracts
519
CY2023Q4 us-gaap Investment Owned Underlying Face Amount At Market Value
InvestmentOwnedUnderlyingFaceAmountAtMarketValue
21019500
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
325083
CY2023Q4 us-gaap Tax Basis Of Investments Unrealized Appreciation Depreciation Net
TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet
325083
CY2023Q4 us-gaap Investment Owned Balance Contracts
InvestmentOwnedBalanceContracts
3282
CY2023Q4 us-gaap Investment Owned Underlying Face Amount At Market Value
InvestmentOwnedUnderlyingFaceAmountAtMarketValue
75023894
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
-9139633
CY2023Q4 us-gaap Tax Basis Of Investments Unrealized Appreciation Depreciation Net
TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet
-9139633
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
-17299247
CY2023Q4 us-gaap Tax Basis Of Investments Unrealized Appreciation Depreciation Net
TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet
-17299247
CY2022Q4 us-gaap Investment Interest Rate
InvestmentInterestRate
0.0334
CY2022Q4 us-gaap Investment Maturity Date
InvestmentMaturityDate
2023-01-05
CY2022Q4 us-gaap Investment Owned Percent Of Net Assets
InvestmentOwnedPercentOfNetAssets
0.0932
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
99979833
CY2022Q4 us-gaap Investment Owned Underlying Face Amount At Market Value
InvestmentOwnedUnderlyingFaceAmountAtMarketValue
100000000
CY2022Q4 us-gaap Investment Interest Rate
InvestmentInterestRate
0.04285
CY2022Q4 us-gaap Investment Maturity Date
InvestmentMaturityDate
2023-03-02
CY2022Q4 us-gaap Investment Owned Percent Of Net Assets
InvestmentOwnedPercentOfNetAssets
0.3935
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
422100973
CY2022Q4 us-gaap Investment Owned Underlying Face Amount At Market Value
InvestmentOwnedUnderlyingFaceAmountAtMarketValue
425000000
CY2022Q4 us-gaap Investment Interest Rate
InvestmentInterestRate
0.0427
CY2022Q4 us-gaap Investment Maturity Date
InvestmentMaturityDate
2023-03-09
CY2022Q4 us-gaap Investment Owned Percent Of Net Assets
InvestmentOwnedPercentOfNetAssets
0.0463
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
49617380
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
571698186
CY2022Q4 dba Investments In And Advances To Affiliates At Cost
InvestmentsInAndAdvancesToAffiliatesAtCost
89044868
CY2022Q4 us-gaap Investment Owned Percent Of Net Assets
InvestmentOwnedPercentOfNetAssets
0.0829
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
88980698
CY2022Q4 us-gaap Investment Owned Balance Shares
InvestmentOwnedBalanceShares
844700
CY2022Q4 us-gaap Investment Interest Rate
InvestmentInterestRate
0.0422
CY2022Q4 dba Investments In And Advances To Affiliates At Cost
InvestmentsInAndAdvancesToAffiliatesAtCost
428581904
CY2022Q4 us-gaap Investment Owned Percent Of Net Assets
InvestmentOwnedPercentOfNetAssets
0.3995
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
428581904
CY2022Q4 us-gaap Investment Owned Balance Shares
InvestmentOwnedBalanceShares
428581904
CY2022Q4 dba Investments In And Advances To Affiliates At Cost
InvestmentsInAndAdvancesToAffiliatesAtCost
517626772
CY2022Q4 us-gaap Investment Owned Percent Of Net Assets
InvestmentOwnedPercentOfNetAssets
0.4824
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
517562602
CY2022Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
1089144428
CY2022Q4 us-gaap Investment Owned Percent Of Net Assets
InvestmentOwnedPercentOfNetAssets
1.0154
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
1089260788
CY2022Q4 us-gaap Good Faith And Margin Deposits With Broker Dealers
GoodFaithAndMarginDepositsWithBrokerDealers
397240000
CY2022Q4 us-gaap Investment Owned Balance Contracts
InvestmentOwnedBalanceContracts
4225
CY2022Q4 us-gaap Investment Owned Underlying Face Amount At Market Value
InvestmentOwnedUnderlyingFaceAmountAtMarketValue
132453750
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
6908542
CY2022Q4 us-gaap Tax Basis Of Investments Unrealized Appreciation Depreciation Net
TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet
6908542
CY2022Q4 us-gaap Investment Owned Balance Contracts
InvestmentOwnedBalanceContracts
1923
CY2022Q4 us-gaap Investment Owned Underlying Face Amount At Market Value
InvestmentOwnedUnderlyingFaceAmountAtMarketValue
136220513
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
5878684
CY2022Q4 us-gaap Tax Basis Of Investments Unrealized Appreciation Depreciation Net
TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet
5878684
CY2022Q4 us-gaap Investment Owned Balance Contracts
InvestmentOwnedBalanceContracts
1548
CY2022Q4 us-gaap Investment Owned Underlying Face Amount At Market Value
InvestmentOwnedUnderlyingFaceAmountAtMarketValue
62152200
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
-20805661
CY2022Q4 us-gaap Tax Basis Of Investments Unrealized Appreciation Depreciation Net
TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet
-20805661
CY2022Q4 us-gaap Investment Owned Balance Contracts
InvestmentOwnedBalanceContracts
1433
CY2022Q4 us-gaap Investment Owned Underlying Face Amount At Market Value
InvestmentOwnedUnderlyingFaceAmountAtMarketValue
62801225
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
-16415477
CY2022Q4 us-gaap Tax Basis Of Investments Unrealized Appreciation Depreciation Net
TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet
-16415477
CY2022Q4 us-gaap Investment Owned Balance Contracts
InvestmentOwnedBalanceContracts
489
CY2022Q4 us-gaap Investment Owned Underlying Face Amount At Market Value
InvestmentOwnedUnderlyingFaceAmountAtMarketValue
45532013
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
352262
CY2022Q4 us-gaap Tax Basis Of Investments Unrealized Appreciation Depreciation Net
TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet
352262
CY2022Q4 us-gaap Investment Owned Balance Contracts
InvestmentOwnedBalanceContracts
2513
CY2022Q4 us-gaap Investment Owned Underlying Face Amount At Market Value
InvestmentOwnedUnderlyingFaceAmountAtMarketValue
88156040
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
4307
CY2022Q4 us-gaap Tax Basis Of Investments Unrealized Appreciation Depreciation Net
TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet
4307
CY2022Q4 us-gaap Investment Owned Balance Contracts
InvestmentOwnedBalanceContracts
2155
CY2022Q4 us-gaap Investment Owned Underlying Face Amount At Market Value
InvestmentOwnedUnderlyingFaceAmountAtMarketValue
136109800
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
2711290
CY2022Q4 us-gaap Tax Basis Of Investments Unrealized Appreciation Depreciation Net
TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet
2711290
CY2022Q4 us-gaap Investment Owned Balance Contracts
InvestmentOwnedBalanceContracts
4699
CY2022Q4 us-gaap Investment Owned Underlying Face Amount At Market Value
InvestmentOwnedUnderlyingFaceAmountAtMarketValue
122174000
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
6081100
CY2022Q4 us-gaap Tax Basis Of Investments Unrealized Appreciation Depreciation Net
TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet
6081100
CY2022Q4 us-gaap Investment Owned Balance Contracts
InvestmentOwnedBalanceContracts
1926
CY2022Q4 us-gaap Investment Owned Underlying Face Amount At Market Value
InvestmentOwnedUnderlyingFaceAmountAtMarketValue
120832425
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
504273
CY2022Q4 us-gaap Tax Basis Of Investments Unrealized Appreciation Depreciation Net
TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet
504273
CY2022Q4 us-gaap Investment Owned Balance Contracts
InvestmentOwnedBalanceContracts
691
CY2022Q4 us-gaap Investment Owned Underlying Face Amount At Market Value
InvestmentOwnedUnderlyingFaceAmountAtMarketValue
28804335
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
-617404
CY2022Q4 us-gaap Tax Basis Of Investments Unrealized Appreciation Depreciation Net
TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet
-617404
CY2022Q4 us-gaap Investment Owned Balance Contracts
InvestmentOwnedBalanceContracts
6811
CY2022Q4 us-gaap Investment Owned Underlying Face Amount At Market Value
InvestmentOwnedUnderlyingFaceAmountAtMarketValue
137157193
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
6430405
CY2022Q4 us-gaap Tax Basis Of Investments Unrealized Appreciation Depreciation Net
TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet
6430405
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
-8967679
CY2022Q4 us-gaap Tax Basis Of Investments Unrealized Appreciation Depreciation Net
TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet
-8967679
CY2023 us-gaap Interest Income Operating
InterestIncomeOperating
19053854
CY2022 us-gaap Interest Income Operating
InterestIncomeOperating
8840965
CY2021 us-gaap Interest Income Operating
InterestIncomeOperating
167245
CY2023 us-gaap Dividend Income Operating
DividendIncomeOperating
24359948
CY2022 us-gaap Dividend Income Operating
DividendIncomeOperating
12480118
CY2021 us-gaap Dividend Income Operating
DividendIncomeOperating
146646
CY2023 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
43413802
CY2022 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
21321083
CY2021 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
313891
CY2023 us-gaap Investment Company General Partner Advisory Service
InvestmentCompanyGeneralPartnerAdvisoryService
7445363
CY2022 us-gaap Investment Company General Partner Advisory Service
InvestmentCompanyGeneralPartnerAdvisoryService
13606141
CY2021 us-gaap Investment Company General Partner Advisory Service
InvestmentCompanyGeneralPartnerAdvisoryService
7600452
CY2023 us-gaap Floor Brokerage Exchange And Clearance Fees
FloorBrokerageExchangeAndClearanceFees
526069
CY2022 us-gaap Floor Brokerage Exchange And Clearance Fees
FloorBrokerageExchangeAndClearanceFees
1063782
CY2021 us-gaap Floor Brokerage Exchange And Clearance Fees
FloorBrokerageExchangeAndClearanceFees
591381
CY2023 us-gaap Interest Expense
InterestExpense
148839
CY2022 us-gaap Interest Expense
InterestExpense
97198
CY2021 us-gaap Interest Expense
InterestExpense
10839
CY2023 us-gaap Operating Expenses
OperatingExpenses
8120271
CY2022 us-gaap Operating Expenses
OperatingExpenses
14767121
CY2021 us-gaap Operating Expenses
OperatingExpenses
8202672
CY2023 us-gaap Investment Company Contractual Fee Waived
InvestmentCompanyContractualFeeWaived
463155
CY2022 us-gaap Investment Company Contractual Fee Waived
InvestmentCompanyContractualFeeWaived
697589
CY2021 us-gaap Investment Company Contractual Fee Waived
InvestmentCompanyContractualFeeWaived
163033
CY2023 dba Operating Expenses Net
OperatingExpensesNet
7657116
CY2022 dba Operating Expenses Net
OperatingExpensesNet
14069532
CY2021 dba Operating Expenses Net
OperatingExpensesNet
8039639
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
35756686
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
7251551
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
7251551
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-7725748
CY2023 us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
74
CY2022 us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
1
CY2021 us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
-5
CY2021 dba Net Realized Gain Loss On Capital Gain Distributions From Affiliated Investments
NetRealizedGainLossOnCapitalGainDistributionsFromAffiliatedInvestments
15129
CY2023 us-gaap Gain Loss On Sale Of Commodity Contracts
GainLossOnSaleOfCommodityContracts
32701174
CY2022 us-gaap Gain Loss On Sale Of Commodity Contracts
GainLossOnSaleOfCommodityContracts
-31195234
CY2021 us-gaap Gain Loss On Sale Of Commodity Contracts
GainLossOnSaleOfCommodityContracts
205864720
CY2023 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
32701248
CY2022 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
-31195233
CY2021 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
205879844
CY2023 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
171804
CY2022 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
178637
CY2021 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-9530
CY2023 dba Unrealized Gain Loss On Affiliated Investments
UnrealizedGainLossOnAffiliatedInvestments
279064
CY2022 dba Unrealized Gain Loss On Affiliated Investments
UnrealizedGainLossOnAffiliatedInvestments
-240740
CY2021 dba Unrealized Gain Loss On Affiliated Investments
UnrealizedGainLossOnAffiliatedInvestments
-38011
CY2023 us-gaap Unrealized Gain Loss On Commodity Contracts
UnrealizedGainLossOnCommodityContracts
-8331568
CY2022 us-gaap Unrealized Gain Loss On Commodity Contracts
UnrealizedGainLossOnCommodityContracts
-43963475
CY2021 us-gaap Unrealized Gain Loss On Commodity Contracts
UnrealizedGainLossOnCommodityContracts
-36272362
CY2023 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-7880700
CY2022 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-44025578
CY2021 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-36319903
CY2023 us-gaap Investment Company Realized And Unrealized Gain Loss On Investment And Foreign Currency
InvestmentCompanyRealizedAndUnrealizedGainLossOnInvestmentAndForeignCurrency
24820548
CY2022 us-gaap Investment Company Realized And Unrealized Gain Loss On Investment And Foreign Currency
InvestmentCompanyRealizedAndUnrealizedGainLossOnInvestmentAndForeignCurrency
-75220811
CY2021 us-gaap Investment Company Realized And Unrealized Gain Loss On Investment And Foreign Currency
InvestmentCompanyRealizedAndUnrealizedGainLossOnInvestmentAndForeignCurrency
169559941
CY2023 us-gaap Net Income Loss
NetIncomeLoss
60577234
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-67969260
CY2021 us-gaap Net Income Loss
NetIncomeLoss
161834193
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
1072706930
CY2023 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
135445983
CY2023 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
530223496
CY2023 dba Stockholders Equity Period Increase Decrease Due To Share Transactions
StockholdersEquityPeriodIncreaseDecreaseDueToShareTransactions
-394777513
CY2023 us-gaap Partners Capital Account Return Of Capital
PartnersCapitalAccountReturnOfCapital
34240081
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
35756686
CY2023 us-gaap Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments
32701248
CY2023 us-gaap Marketable Securities Unrealized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairments
-7880700
CY2023 us-gaap Net Income Loss
NetIncomeLoss
60577234
CY2023 us-gaap Stockholders Equity Period Increase Decrease
StockholdersEquityPeriodIncreaseDecrease
-368440360
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
704266570
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
1018200047
CY2022 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1560144663
CY2022 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
1431998432
CY2022 dba Stockholders Equity Period Increase Decrease Due To Share Transactions
StockholdersEquityPeriodIncreaseDecreaseDueToShareTransactions
128146231
CY2022 us-gaap Partners Capital Account Return Of Capital
PartnersCapitalAccountReturnOfCapital
5670088
CY2022 us-gaap Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments
-31195233
CY2022 us-gaap Marketable Securities Unrealized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairments
-44025578
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-67969260
CY2022 us-gaap Stockholders Equity Period Increase Decrease
StockholdersEquityPeriodIncreaseDecrease
54506883
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
1072706930
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
648463433
CY2021 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
538270063
CY2021 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
330367642
CY2021 dba Stockholders Equity Period Increase Decrease Due To Share Transactions
StockholdersEquityPeriodIncreaseDecreaseDueToShareTransactions
207902421
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-7725748
CY2021 us-gaap Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments
205879844
CY2021 us-gaap Marketable Securities Unrealized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairments
-36319903
CY2021 us-gaap Net Income Loss
NetIncomeLoss
161834193
CY2021 us-gaap Stockholders Equity Period Increase Decrease
StockholdersEquityPeriodIncreaseDecrease
369736614
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
1018200047
CY2023 us-gaap Net Income Loss
NetIncomeLoss
60577234
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-67969260
CY2021 us-gaap Net Income Loss
NetIncomeLoss
161834193
CY2023 us-gaap Payments For Purchase Of Securities Operating Activities
PaymentsForPurchaseOfSecuritiesOperatingActivities
1077203551
CY2022 us-gaap Payments For Purchase Of Securities Operating Activities
PaymentsForPurchaseOfSecuritiesOperatingActivities
1643746028
CY2021 us-gaap Payments For Purchase Of Securities Operating Activities
PaymentsForPurchaseOfSecuritiesOperatingActivities
493917062
CY2023 us-gaap Proceeds From Sale Of Securities Operating Activities
ProceedsFromSaleOfSecuritiesOperatingActivities
1325000074
CY2022 us-gaap Proceeds From Sale Of Securities Operating Activities
ProceedsFromSaleOfSecuritiesOperatingActivities
1284011601
CY2021 us-gaap Proceeds From Sale Of Securities Operating Activities
ProceedsFromSaleOfSecuritiesOperatingActivities
500999995
CY2023 dba Cost Of Affiliated Investments Purchased
CostOfAffiliatedInvestmentsPurchased
1461510451
CY2022 dba Cost Of Affiliated Investments Purchased
CostOfAffiliatedInvestmentsPurchased
3155758046
CY2021 dba Cost Of Affiliated Investments Purchased
CostOfAffiliatedInvestmentsPurchased
1510057786
CY2023 dba Proceeds From Affiliated Investments Sold
ProceedsFromAffiliatedInvestmentsSold
1611536659
CY2022 dba Proceeds From Affiliated Investments Sold
ProceedsFromAffiliatedInvestmentsSold
3465598343
CY2021 dba Proceeds From Affiliated Investments Sold
ProceedsFromAffiliatedInvestmentsSold
1108185850
CY2023 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
-18883103
CY2022 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
-8776905
CY2021 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
-167245
CY2023 dba Realized Gain Loss On Marketable Securities
RealizedGainLossOnMarketableSecurities
74
CY2022 dba Realized Gain Loss On Marketable Securities
RealizedGainLossOnMarketableSecurities
1
CY2021 dba Realized Gain Loss On Marketable Securities
RealizedGainLossOnMarketableSecurities
-5
CY2023 dba Unrealized Gain Loss On Marketable Securities And Affiliated Investments
UnrealizedGainLossOnMarketableSecuritiesAndAffiliatedInvestments
450868
CY2022 dba Unrealized Gain Loss On Marketable Securities And Affiliated Investments
UnrealizedGainLossOnMarketableSecuritiesAndAffiliatedInvestments
-62103
CY2021 dba Unrealized Gain Loss On Marketable Securities And Affiliated Investments
UnrealizedGainLossOnMarketableSecuritiesAndAffiliatedInvestments
-47541
CY2023 dba Increase Decrease In Variation Margin
IncreaseDecreaseInVariationMargin
-9327401
CY2022 dba Increase Decrease In Variation Margin
IncreaseDecreaseInVariationMargin
10364071
CY2021 dba Increase Decrease In Variation Margin
IncreaseDecreaseInVariationMargin
-18188960
CY2023 us-gaap Increase Decrease In Dividends Receivable
IncreaseDecreaseInDividendsReceivable
-363052
CY2022 us-gaap Increase Decrease In Dividends Receivable
IncreaseDecreaseInDividendsReceivable
1750392
CY2021 us-gaap Increase Decrease In Dividends Receivable
IncreaseDecreaseInDividendsReceivable
10576
CY2023 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
-305927
CY2022 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
87663
CY2021 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
334784
CY2023 us-gaap Increase Decrease In Payables To Broker Dealers
IncreaseDecreaseInPayablesToBrokerDealers
533
CY2022 us-gaap Increase Decrease In Payables To Broker Dealers
IncreaseDecreaseInPayablesToBrokerDealers
-2866
CY2021 us-gaap Increase Decrease In Payables To Broker Dealers
IncreaseDecreaseInPayablesToBrokerDealers
519
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
448450979
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-138607859
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-214560822
CY2023 us-gaap Payments Of Dividends
PaymentsOfDividends
33903924
CY2022 us-gaap Payments Of Dividends
PaymentsOfDividends
5670088
CY2023 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
133371678
CY2022 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1560144663
CY2021 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
538270063
CY2023 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
543197667
CY2022 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1415866716
CY2021 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
330367642
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-443729913
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
138607859
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
207902421
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
4721066
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-6658401
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6658401
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4721066
CY2023 us-gaap Interest Paid Net
InterestPaidNet
148839
CY2022 us-gaap Interest Paid Net
InterestPaidNet
97198
CY2021 us-gaap Interest Paid Net
InterestPaidNet
10839
CY2006Q3 dba Number Of Series Of Trusts
NumberOfSeriesOfTrusts
7
CY2015Q1 us-gaap General Partners Capital Account Units Outstanding
GeneralPartnersCapitalAccountUnitsOutstanding
40
CY2023 dba Treasury Obligation Measurement Maximum Maturity Period
TreasuryObligationMeasurementMaximumMaturityPeriod
P12M
CY2023 dba Minimum Number Of Creation Units Of Shares That Can Be Purchased
MinimumNumberOfCreationUnitsOfSharesThatCanBePurchased
1
CY2023 dba Number Of Shares Issued Per Creation Unit
NumberOfSharesIssuedPerCreationUnit
50000
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<div style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:3.333%;display:inline-flex;justify-content:flex-start;">B.</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Accounting Estimates</span></div></div><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates by a significant amount. In addition, the Fund monitors for material events or transactions that may occur or become known after the period-end date and before the date the financial statements are issued.</span></p>
CY2023 dba Partners Capital Distribution Date To Be Paid Day Month And Year
PartnersCapitalDistributionDateToBePaidDayMonthAndYear
2023-12-22
CY2023 dba Partners Capital Distribution Date Of Record Day Month And Year
PartnersCapitalDistributionDateOfRecordDayMonthAndYear
2023-12-19
CY2023 us-gaap Undistributed Earnings
UndistributedEarnings
336157
CY2023 us-gaap Other Nonrecurring Expense
OtherNonrecurringExpense
0
CY2022 us-gaap Other Nonrecurring Expense
OtherNonrecurringExpense
0
CY2021 us-gaap Other Nonrecurring Expense
OtherNonrecurringExpense
0
CY2023 dba Average Charges Paid To Broker Per Round Turn Trade Maximum
AverageChargesPaidToBrokerPerRoundTurnTradeMaximum
7.00
CY2022 dba Average Charges Paid To Broker Per Round Turn Trade Maximum
AverageChargesPaidToBrokerPerRoundTurnTradeMaximum
7.00
CY2021 dba Average Charges Paid To Broker Per Round Turn Trade Maximum
AverageChargesPaidToBrokerPerRoundTurnTradeMaximum
7.00
CY2023Q4 us-gaap Financial Instruments Owned At Fair Value
FinancialInstrumentsOwnedAtFairValue
693472855
CY2022Q4 us-gaap Financial Instruments Owned Us Government And Agency Obligations At Fair Value
FinancialInstrumentsOwnedUSGovernmentAndAgencyObligationsAtFairValue
571698186
CY2023 dba Management Fee Per Annum Of Daily Net Assets
ManagementFeePerAnnumOfDailyNetAssets
0.0085
CY2023 us-gaap Investment Company Contractual Fee Waived
InvestmentCompanyContractualFeeWaived
463155
CY2022 us-gaap Investment Company Contractual Fee Waived
InvestmentCompanyContractualFeeWaived
697589
CY2021 us-gaap Investment Company Contractual Fee Waived
InvestmentCompanyContractualFeeWaived
163033
CY2023 us-gaap Due To And From Broker Dealers And Clearing Organizations Disclosure
DueToAndFromBrokerDealersAndClearingOrganizationsDisclosure
<p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Note 5 - Deposits with Commodity Broker and Custodian</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Fund defines cash as cash held by the Custodian. There were </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">no</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> cash equivalents held by the Fund as of December 31, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2023 and 2022. The Fund considers investments in money market funds to be investments in securities and, accordingly, includes them in its Schedule of Investments.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Fund may deposit cash, United States Treasury Obligations, T-Bill ETFs and money market mutual funds with the Commodity Broker as margin, to the extent permissible under CFTC rules. The combination of the Fund’s deposits with its Commodity Broker of cash and United States Treasury Obligations and the unrealized profit or loss on open futures contracts represents the Fund’s overall equity in its broker trading account. To meet the Fund’s maintenance margin requirements, the Fund holds United States Treasury Obligations with the Commodity Broker. The Fund transfers cash to the Commodity Broker to satisfy variation margin requirements. The Fund earns interest on any excess cash deposited with the Commodity Broker and incurs interest expense on any deficit balance with the Commodity Broker.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The brokerage agreement with the Commodity Broker provides for the net settlement of all financial instruments covered by the agreement in the event of default or termination of any one contract. The Managing Owner will utilize any excess cash held at the Commodity Broker to offset any realized losses incurred in the commodity futures contracts, if available. To the extent that any excess cash held at the Commodity Broker is not adequate to cover any realized losses, a portion of the United States Treasury Obligations and T-Bill ETFs, if any, on deposit with the Commodity Broker will be sold to make additional cash available. For financial reporting purposes, the Fund offsets financial assets and financial liabilities that are subject to legally enforceable netting arrangements.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Fund’s remaining cash, United States Treasury Obligations, T-Bill ETFs and money market mutual fund holdings are on deposit with the Custodian. The Fund is permitted to temporarily carry a negative or overdrawn balance in its account with the Custodian. The Fund incurs interest expense on any overdraft balance with the Custodian. Such balances, if any at period-end, are shown on the Statements of Financial Condition under the payable caption </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Due to custodian</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Because the Fund's assets are maintained with the Commodity Broker and Custodian, the distress, impairment or failure of the Commodity Broker or Custodian could result in the loss of or delay in access to Fund assets.</span></p>
CY2023Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
CY2022Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
CY2023Q4 us-gaap Financial Instruments Owned Us Government And Agency Obligations At Fair Value
FinancialInstrumentsOwnedUSGovernmentAndAgencyObligationsAtFairValue
342956644
CY2023Q4 dba Financial Instruments Owned Exchange Traded Fund
FinancialInstrumentsOwnedExchangeTradedFund
119734949
CY2023Q4 dba Financial Instruments Owned Money Market Mutual Fund At Fair Value
FinancialInstrumentsOwnedMoneyMarketMutualFundAtFairValue
248080509
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
710772102
CY2023Q4 us-gaap Investment Owned Unrecognized Unrealized Appreciation
InvestmentOwnedUnrecognizedUnrealizedAppreciation
15443843
CY2023Q4 us-gaap Investment Owned Unrecognized Unrealized Depreciation
InvestmentOwnedUnrecognizedUnrealizedDepreciation
32743090
CY2023Q4 us-gaap Investment Owned Unrecognized Unrealized Appreciation Depreciation Net
InvestmentOwnedUnrecognizedUnrealizedAppreciationDepreciationNet
-17299247
CY2022Q4 dba Financial Instruments Owned Exchange Traded Fund
FinancialInstrumentsOwnedExchangeTradedFund
88980698
CY2022Q4 dba Financial Instruments Owned Money Market Mutual Fund At Fair Value
FinancialInstrumentsOwnedMoneyMarketMutualFundAtFairValue
428581904
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
1089260788
CY2022Q4 us-gaap Investment Owned Unrecognized Unrealized Appreciation
InvestmentOwnedUnrecognizedUnrealizedAppreciation
28870863
CY2022Q4 us-gaap Investment Owned Unrecognized Unrealized Depreciation
InvestmentOwnedUnrecognizedUnrealizedDepreciation
37838542
CY2022Q4 us-gaap Investment Owned Unrecognized Unrealized Appreciation Depreciation Net
InvestmentOwnedUnrecognizedUnrealizedAppreciationDepreciationNet
-8967679
CY2022Q4 us-gaap Financial Instruments Owned At Fair Value
FinancialInstrumentsOwnedAtFairValue
1080293109
CY2023 dba Minimum Number Of Creation Units Of Shares That Can Be Purchased
MinimumNumberOfCreationUnitsOfSharesThatCanBePurchased
1
CY2023 dba Number Of Shares Issued Per Creation Unit
NumberOfSharesIssuedPerCreationUnit
50000
CY2023 dba Minimum Number Of Creation Units Of Shares That Can Be Redeemed
MinimumNumberOfCreationUnitsOfSharesThatCanBeRedeemed
1
CY2023 dba Number Of Shares Redeemable Per Creation Unit
NumberOfSharesRedeemablePerCreationUnit
50000
CY2022Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
20.16
CY2021Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
19.73
CY2020Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
16.13
CY2023 us-gaap Investment Company Gain Loss On Investment Per Share
InvestmentCompanyGainLossOnInvestmentPerShare
0.68
CY2022 us-gaap Investment Company Gain Loss On Investment Per Share
InvestmentCompanyGainLossOnInvestmentPerShare
0.44
CY2021 us-gaap Investment Company Gain Loss On Investment Per Share
InvestmentCompanyGainLossOnInvestmentPerShare
3.76
CY2023 us-gaap Investment Company Investment Income Loss Per Share
InvestmentCompanyInvestmentIncomeLossPerShare
0.86
CY2022 us-gaap Investment Company Investment Income Loss Per Share
InvestmentCompanyInvestmentIncomeLossPerShare
0.09
CY2021 us-gaap Investment Company Investment Income Loss Per Share
InvestmentCompanyInvestmentIncomeLossPerShare
-0.16
CY2023 us-gaap Investment Company Investment Income Loss From Operations Per Share
InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare
1.54
CY2022 us-gaap Investment Company Investment Income Loss From Operations Per Share
InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare
0.53
CY2021 us-gaap Investment Company Investment Income Loss From Operations Per Share
InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare
3.60
CY2023 us-gaap Investment Company Tax Return Of Capital Distribution Per Share
InvestmentCompanyTaxReturnOfCapitalDistributionPerShare
-0.96
CY2022 us-gaap Investment Company Tax Return Of Capital Distribution Per Share
InvestmentCompanyTaxReturnOfCapitalDistributionPerShare
-0.10
CY2023Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
20.74
CY2022Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
20.16
CY2021Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
19.73
CY2022Q4 dba Market Value Per Share
MarketValuePerShare
20.15
CY2021Q4 dba Market Value Per Share
MarketValuePerShare
19.75
CY2020Q4 dba Market Value Per Share
MarketValuePerShare
16.14
CY2023Q4 dba Market Value Per Share
MarketValuePerShare
20.73
CY2022Q4 dba Market Value Per Share
MarketValuePerShare
20.15
CY2021Q4 dba Market Value Per Share
MarketValuePerShare
19.75
CY2023 us-gaap Investment Company Investment Income Loss Ratio
InvestmentCompanyInvestmentIncomeLossRatio
0.0409
CY2022 us-gaap Investment Company Investment Income Loss Ratio
InvestmentCompanyInvestmentIncomeLossRatio
0.0045
CY2021 us-gaap Investment Company Investment Income Loss Ratio
InvestmentCompanyInvestmentIncomeLossRatio
-0.0086
CY2023 us-gaap Investment Company Expense Ratio Including Voluntary Fee Waiver
InvestmentCompanyExpenseRatioIncludingVoluntaryFeeWaiver
0.0087
CY2022 us-gaap Investment Company Expense Ratio Including Voluntary Fee Waiver
InvestmentCompanyExpenseRatioIncludingVoluntaryFeeWaiver
0.0088
CY2021 us-gaap Investment Company Expense Ratio Including Voluntary Fee Waiver
InvestmentCompanyExpenseRatioIncludingVoluntaryFeeWaiver
0.0090
CY2023 dba Average Net Assets To Expenses Prior To Waivers
AverageNetAssetsToExpensesPriorToWaivers
0.0093
CY2022 dba Average Net Assets To Expenses Prior To Waivers
AverageNetAssetsToExpensesPriorToWaivers
0.0092
CY2021 dba Average Net Assets To Expenses Prior To Waivers
AverageNetAssetsToExpensesPriorToWaivers
0.0092
CY2023 us-gaap Investment Company Total Return
InvestmentCompanyTotalReturn
0.0759
CY2022 us-gaap Investment Company Total Return
InvestmentCompanyTotalReturn
0.0268
CY2021 us-gaap Investment Company Total Return
InvestmentCompanyTotalReturn
0.2232
CY2023 dba Return At Market Value
ReturnAtMarketValue
0.0758
CY2022 dba Return At Market Value
ReturnAtMarketValue
0.0253
CY2021 dba Return At Market Value
ReturnAtMarketValue
0.2237
CY2023Q4 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023Q4 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2023Q4 dba Non Rule10 B51 Arr Modified Flag
NonRule10B51ArrModifiedFlag
false
CY2023Q4 dba Rule10 B51 Arr Modified Flag
Rule10B51ArrModifiedFlag
false
CY2023Q4 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2023Q4 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0000950170-24-019060-index-headers.html Edgar Link pending
0000950170-24-019060-index.html Edgar Link pending
0000950170-24-019060.txt Edgar Link pending
0000950170-24-019060-xbrl.zip Edgar Link pending
dba-20231231.htm Edgar Link pending
dba-20231231.xsd Edgar Link pending
dba-ex23_1.htm Edgar Link pending
dba-ex31_1.htm Edgar Link pending
dba-ex31_2.htm Edgar Link pending
dba-20231231_htm.xml Edgar Link completed
dba-ex32_1.htm Edgar Link pending
dba-ex32_2.htm Edgar Link pending
dba-ex97.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
img237653160_0.jpg Edgar Link pending
img237653160_1.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable